• A novel sealed in situ fermentation strategy increased the baicalein loading rate. • This strategy addressed the issues of easy sedimentation of baicalein. • BC-baicalein sealed fermentation membrane (BC-BP) showed enhanced antioxidant activity. • BC-BP demonstrated improved antibacterial and wound-healing promotion ability. Bacterial cellulose (BC) is a potential wound dressing but lacks antibacterial and anti-inflammatory properties, so in situ modification is required. However, the conventional aerobic Komagataeibacter xylinus for BC production only grows at air-liquid interface with long cycles, which may cause degradation, inactivation, or sedimentation of water-insoluble modifiers, leading to low in-situ modification efficiency. Herein, a novel sealed fermentation in-situ modification strategy was developed using Kosakonia oryzaendophytica FY-07, which enables deep fermentation and gas production. Water-insoluble baicalein was uniformly suspended by xanthan gum. Then, fermentation-generated gas boosted internal pressure, enhanced modifier penetration and formed compact products. This strategy increased baicalein loading capacity by 1.21-fold, achieving a value of 431.6 ± 5.6 mg/g. The resulting BC-baicalein sealed fermentation composite membrane (BC-BP) showed improved antibacterial, antioxidant and mechanical properties (2.5-fold higher tensile strength), and 15% higher mouse wound closure rate on day 12. These results verified the strategy’s superiority, which is applicable to both soluble and insoluble modifiers, improving modification efficiency and expanding BC applications.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: